Literature DB >> 7213416

Studies of the mode of action of antitumour triazenes and triazines-II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes.

A Gescher, J A Hickman, R J Simmonds, M F Stevens, K Vaughan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7213416     DOI： 10.1016/0006-2952(81)90288-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

Review 1.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.

Authors:  B J Foster; D R Newell; J Carmichael; A L Harris; L A Gumbrell; M Jones; P M Goodard; A H Calvert
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

3.  N-methylformamide: antitumour activity and metabolism in mice.

Authors:  A Gescher; N W Gibson; J A Hickman; S P Langdon; D Ross; G Atassi
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

4.  Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives.

Authors:  Michele Tonelli; Iana Vazzana; Bruno Tasso; Vito Boido; Fabio Sparatore; Maurizio Fermeglia; Maria Silvia Paneni; Paola Posocco; Sabrina Pricl; Paolo La Colla; Cristina Ibba; Barbara Secci; Gabriella Collu; Roberta Loddo
Journal:  Bioorg Med Chem       Date:  2009-05-15       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.